Uniunea Europeană -
islandeză -
EMA (European Medicines Agency)
kesimpta
novartis ireland ltd - ofatumumab - heila-og mænusigg, köstum tilkynnt - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.
Islanda -
islandeză -
LYFJASTOFNUN (Icelandic Medicines Agency)
orfiril magasýruþolin tafla 150 mg
desitin arzneimittel gmbh - natrii valproas - magasýruþolin tafla - 150 mg
Islanda -
islandeză -
LYFJASTOFNUN (Icelandic Medicines Agency)
orfiril magasýruþolin tafla 600 mg
desitin arzneimittel gmbh - natrii valproas - magasýruþolin tafla - 600 mg
Islanda -
islandeză -
LYFJASTOFNUN (Icelandic Medicines Agency)
orfiril mixtúra, lausn 60 mg/ml
desitin arzneimittel gmbh - natrii valproas - mixtúra, lausn - 60 mg/ml
Islanda -
islandeză -
LYFJASTOFNUN (Icelandic Medicines Agency)
topimax filmuhúðuð tafla 100 mg
janssen-cilag ab - topiramatum inn - filmuhúðuð tafla - 100 mg
Islanda -
islandeză -
LYFJASTOFNUN (Icelandic Medicines Agency)
topimax filmuhúðuð tafla 200 mg
janssen-cilag ab - topiramatum inn - filmuhúðuð tafla - 200 mg
Islanda -
islandeză -
LYFJASTOFNUN (Icelandic Medicines Agency)
topimax filmuhúðuð tafla 25 mg
janssen-cilag ab - topiramatum inn - filmuhúðuð tafla - 25 mg
Islanda -
islandeză -
LYFJASTOFNUN (Icelandic Medicines Agency)
topimax filmuhúðuð tafla 50 mg
janssen-cilag ab - topiramatum inn - filmuhúðuð tafla - 50 mg
Islanda -
islandeză -
LYFJASTOFNUN (Icelandic Medicines Agency)
topimax hart hylki 15 mg
janssen-cilag ab - topiramatum inn - hart hylki - 15 mg
Islanda -
islandeză -
LYFJASTOFNUN (Icelandic Medicines Agency)
topiramat actavis filmuhúðuð tafla 100 mg
actavis group ptc ehf. - topiramatum inn - filmuhúðuð tafla - 100 mg